Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial (Q38438519)
Jump to navigation
Jump to search
scientific article published on 28 May 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial |
scientific article published on 28 May 2011 |
Statements
1 reference
Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial (English)
1 reference
1 reference
Frederik Barkhof
1 reference
Trygve Holmoy
1 reference
Joep Killestein
1 reference
Reinhold Vieth
1 reference
Raymond Hupperts
1 reference
Luigi M E Grimaldi
1 reference
Peter Rieckmann
1 reference
Myriam Schluep
1 reference
Ulrike Hostalek
1 reference
Lizette Ghazi-Visser
1 reference
Manolo Beelke
1 reference
SOLAR study group
1 reference
28 May 2011
1 reference
1 reference
311
1 reference
1-2
1 reference
44-49
1 reference
Identifiers
1 reference
1 reference